These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3150257)

  • 1. [Evaluation of an automated system of measuring erythrocyte aggregation in dysglobulinemia treated by plasma exchange].
    Schooneman F; Streiff F; Donner M
    Ann Med Interne (Paris); 1988; 139 Suppl 1():63-5. PubMed ID: 3150257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocyte aggregation in patients treated by plasma exchange or plasma administration].
    Schooneman F; Stoltz JF
    Ann Med Interne (Paris); 1994; 145(5):361-4. PubMed ID: 7985950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythrocyte aggregation in patients with monoclonal gammopathies: effect of plasma exchange treatment].
    Donner M; Schooneman F; Muller S; Stoltz JF
    J Mal Vasc; 1991; 16(3):283-8. PubMed ID: 1940656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red cell aggregation and deformability in plasma cell dyscrasias.
    Volger E; Schmid-Schönbein H; Emmerich B
    Bibl Anat; 1977; (16 Pt 2):513-6. PubMed ID: 414737
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rheologic studies before and after therapeutic cytapheresis and plasma exchange treatment].
    Waxenberger Y; Schäd S; Gross D; Ullrich H; Hohe R; Langer R; Henrich H; Weibecke D
    Beitr Infusionsther; 1992; 30():301-5. PubMed ID: 1284721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathy of undetermined significance: why identification of these patients and assessment of their skeletons is important.
    Berenson JR; Yellin O
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):311-5. PubMed ID: 19717382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A syllectrometric method to study erythrocyte aggregation].
    Pieragalli D; Forconi S; Guerrini M; Acciavatti A; Galigani C; Del Bigo C; Di Perri T
    Ric Clin Lab; 1985; 15 Suppl 1():79-86. PubMed ID: 3929369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and urine light chain levels in benign monoclonal gammapathies, multiple myeloma and Waldenström's macroglobulinaemia.
    Dammacco F; Waldenström J
    Clin Exp Immunol; 1968 Nov; 3(9):911-21. PubMed ID: 4180117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-specific immune competence modulation following plasma exchange.
    Busnach G; Brando B; Sommaruga E; Cappelleri A; Perrino ML; Dal Col A; Minetti L
    Prog Clin Biol Res; 1990; 337():477-9. PubMed ID: 2141174
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood volume and hematocrit value in macroglobulinemia and myeloma.
    Kopp WL; MacKinney AA; Wasson G
    Arch Intern Med; 1969 Apr; 123(4):394-6. PubMed ID: 4976452
    [No Abstract]   [Full Text] [Related]  

  • 11. [Culture in vitro of lymphocytes in 14 cases of monoclonal paraproteinemia].
    Blefari D; Gambertoglio G
    Boll Soc Ital Biol Sper; 1969 May; 45(9):549-52. PubMed ID: 4099297
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significance.
    Castillo JJ; Gertz MA
    Leuk Lymphoma; 2017 Apr; 58(4):773-780. PubMed ID: 27546465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperviscosity syndromes associated with immunoglobulin abnormalities.
    Bloch KJ; Maki DG
    Semin Hematol; 1973 Apr; 10(2):113-24. PubMed ID: 4633222
    [No Abstract]   [Full Text] [Related]  

  • 14. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
    McMaster ML; Caporaso N
    Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal and recovery rate of paraproteins by plasma exchange.
    Busnach G; Perrino ML; Dal Col A; Brando B; Minetti L
    Life Support Syst; 1983; 1 Suppl 1():112-4. PubMed ID: 6443836
    [No Abstract]   [Full Text] [Related]  

  • 16. Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience.
    Frustaci AM; Nichelatti M; Deodato M; Zamprogna G; Minga P; Pioltelli ML; Cairoli R; Tedeschi A
    Hematol Oncol; 2020 Feb; 38(1):111-113. PubMed ID: 31852014
    [No Abstract]   [Full Text] [Related]  

  • 17. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
    Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P
    Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypervolemia in dysproteinemia].
    Piguet H; Courtois H; Levillain M; Deshayes
    Rev Rhum Mal Osteoartic; 1971; 38(8):545-7. PubMed ID: 5003549
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous manifestations of dysproteinemias.
    Dominey AM; Tschen JA
    Dermatol Clin; 1989 Jul; 7(3):449-66. PubMed ID: 2502337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disgnostic significance of fractionation of sera with paraproteins by gel filtration.
    Bischof B; Märki HH; Wuhrmann F
    Helv Med Acta; 1968 Jul; 34(3):265-74. PubMed ID: 4174756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.